- Home
- PBPB vs ABEO Comparison
PBPB vs ABEO Comparison
Compare PBPB & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBPB
- ABEO
- Stock Information
- Founded
- PBPB 1977
- ABEO 1974
- Country
- PBPB United States
- ABEO United States
- Employees
- PBPB N/A
- ABEO N/A
- Industry
- PBPB Restaurants
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- PBPB Consumer Discretionary
- ABEO Health Care
- Exchange
- PBPB Nasdaq
- ABEO Nasdaq
- Market Cap
- PBPB 305.0M
- ABEO 289.2M
- IPO Year
- PBPB 2013
- ABEO 1980
- Fundamental
- Price
- PBPB $17.01
- ABEO $5.64
- Analyst Decision
- PBPB Buy
- ABEO Strong Buy
- Analyst Count
- PBPB 3
- ABEO 6
- Target Price
- PBPB $17.37
- ABEO $18.17
- AVG Volume (30 Days)
- PBPB 1.9M
- ABEO 783.9K
- Earning Date
- PBPB 11-06-2025
- ABEO 11-13-2025
- Dividend Yield
- PBPB N/A
- ABEO N/A
- EPS Growth
- PBPB N/A
- ABEO N/A
- EPS
- PBPB 0.35
- ABEO 0.99
- Revenue
- PBPB $469,138,000.00
- ABEO $400,000.00
- Revenue This Year
- PBPB $5.28
- ABEO N/A
- Revenue Next Year
- PBPB $4.30
- ABEO $324.71
- P/E Ratio
- PBPB $49.14
- ABEO $5.70
- Revenue Growth
- PBPB N/A
- ABEO N/A
- 52 Week Low
- PBPB $7.27
- ABEO $3.93
- 52 Week High
- PBPB $17.04
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- PBPB 58.93
- ABEO 30.38
- Support Level
- PBPB $12.38
- ABEO $5.52
- Resistance Level
- PBPB $17.04
- ABEO $5.82
- Average True Range (ATR)
- PBPB 0.22
- ABEO 0.29
- MACD
- PBPB -0.61
- ABEO -0.16
- Stochastic Oscillator
- PBPB 99.82
- ABEO 7.84
About PBPB Potbelly Corporation
Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.